Literature DB >> 9849868

Conformational analysis of the endogenous mu-opioid agonist endomorphin-1 using NMR spectroscopy and molecular modeling.

B L Podlogar1, M G Paterlini, D M Ferguson, G C Leo, D A Demeter, F K Brown, A B Reitz.   

Abstract

Endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) is a highly selective and potent agonist of the mu-opioid receptor. To identify structural attributes unique to this opioid peptide and potential sites of recognition, a conformational analysis has been performed using multidimensional NMR and molecular modeling techniques. The spectroscopic results, derived from experiments in both DMSO and water, indicate that endomorphin-1 exists in the cis- and trans-configuration with respect to the Pro-omega bond in approximately 25% and 75% populations, respectively. In DMSO, the cis-configuration adopts a compact sandwich conformation in which the Tyr and Trp aromatic rings pack against the proline ring, whereas the trans-configuration adopts an extended conformation. Although non-random structure was not observed in water, condensed phase molecular dynamics calculations indicate that trans-isomers dominate the population in this higher dielectric medium. Structural comparison of the cis- and trans-configurations with morphine and selective mu-peptide ligands PL-017 and D-TIPP, as well as the delta-selective peptide ligands TIPP (delta-antagonist, mu-agonist) and DPDPE were also performed and suggest the trans-isomer is likely the bioactive form. A hypothesis is proposed to explain mu- and delta-selectivity based on the presence of spatially distinct selectivity pockets among these ligands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849868     DOI: 10.1016/s0014-5793(98)01202-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Stereochemical requirements for receptor recognition of the mu-opioid peptide endomorphin-1.

Authors:  M G Paterlini; F Avitabile; B G Ostrowski; D M Ferguson; P S Portoghese
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

2.  Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligands.

Authors:  Tingyou Li; Kimitaka Shiotani; Anna Miyazaki; Yuko Tsuda; Akihiro Ambo; Yusuke Sasaki; Yunden Jinsmaa; Ewa Marczak; Sharon D Bryant; Lawrence H Lazarus; Yoshio Okada
Journal:  J Med Chem       Date:  2007-05-12       Impact factor: 7.446

3.  Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue.

Authors:  Domenica Torino; Adriano Mollica; Francesco Pinnen; Gino Lucente; Federica Feliciani; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2009-06-06       Impact factor: 2.823

4.  Four-component pharmacophore model for endomorphins toward μ opioid receptor subtypes.

Authors:  Yng-Ching Wu; Tim Jaglinski; Jin-Yuan Hsieh; Jia-Jyun Chiu; Tzen-Yuh Chiang; Chi-Chuan Hwang
Journal:  J Mol Model       Date:  2011-05-27       Impact factor: 1.810

5.  Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides.

Authors:  Yasuko Koda; Mark Del Borgo; Susanne T Wessling; Lawrence H Lazarus; Yoshio Okada; Istvan Toth; Joanne T Blanchfield
Journal:  Bioorg Med Chem       Date:  2008-04-15       Impact factor: 3.641

6.  Rapid phenolic O-glycosylation of small molecules and complex unprotected peptides in aqueous solvent.

Authors:  Tyler J Wadzinski; Angela Steinauer; Liana Hie; Guillaume Pelletier; Alanna Schepartz; Scott J Miller
Journal:  Nat Chem       Date:  2018-04-30       Impact factor: 24.427

7.  Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands.

Authors:  Zhijun Wu; Victor J Hruby
Journal:  ACS Omega       Date:  2019-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.